European Drug Agency Supports Novo Nordisk's Blockbuster Weight-Loss Drug Wegovy For Obesity-Related Heart Failure
Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of Novo Nordisk A/S’ (NYSE:NVO) Wegovy (semaglutide 2.4 mg) label. The label update incorporates data showing that Wegovy,
The European Medicines Agency approved Afqlir and Opuviz to treat age-related macular degeneration while reiterating its ...
DPA International on MSN3h
EU extends authorization of the mpox vaccine to adolescentsThe European Commission on Friday extended the authorization of the Imvanex mpox vaccine to teenagers aged 12 to 17.
By Shubham Batra (Reuters) -European shares slipped on Friday after a rally in the previous session spurred by the U.S.
The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) recommended the granting of ...
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...
The community in west Cavan is rallying around a popular retired local GP in a bid to help pay for specialist cancer therapy ...
Merck & Co. said a European Medicines Agency panel recommended expanded approval of the drugmaker's blockbuster cancer treatment Keytruda in two types of gynecologic cancers.
EMA’s human medicines committee elects Bruno Sepodes as new chair: Amsterdam, The Netherlands Friday, September 20, 2024, ...
This CHMP opinion was made despite broad support for pegcetacoplan from the European retina community and multiple dissenting votes by CHMP members who supported a path to approval.” “We have seen the ...
Mpox, declared a global public health emergency by WHO, has disproportionately affected children and adolescents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback